Skip to main content
. 2018 Jul 31;25(3):1035–1045. doi: 10.1007/s12253-018-0459-8

Fig. 2.

Fig. 2

The probability of progression-free survival alteration depending on XPD/ERCC2 (2251A > C) genotype